337 related articles for article (PubMed ID: 15370466)
1. Protein thiol oxidation and lipid peroxidation in patients with uraemia.
Prakash M; Upadhya S; Prabhu R
Scand J Clin Lab Invest; 2004; 64(6):599-604. PubMed ID: 15370466
[TBL] [Abstract][Full Text] [Related]
2. Carbonyl stress in chronic renal failure: the effect of haemodialysis.
Dursun E; Dursun B; Süleymanlar G; Ozben T
Ann Clin Biochem; 2005 Jan; 42(Pt 1):64-6. PubMed ID: 15802036
[TBL] [Abstract][Full Text] [Related]
3. Serum non-transferrin bound iron in hemodialysis patients not receiving intravenous iron.
Prakash M; Upadhya S; Prabhu R
Clin Chim Acta; 2005 Oct; 360(1-2):194-8. PubMed ID: 15979061
[TBL] [Abstract][Full Text] [Related]
4. Oxidative stress markers in pre-uremic patients.
Annuk M; Fellström B; Akerblom O; Zilmer K; Vihalemm T; Zilmer M
Clin Nephrol; 2001 Oct; 56(4):308-14. PubMed ID: 11680661
[TBL] [Abstract][Full Text] [Related]
5. Oxidative stress markers and C-reactive protein in pediatric patients on hemodialysis.
Elshamaa MF; Sabry S; Nabih M; Elghoroury EA; El-Saaid GS; Ismail AA
Ann Nutr Metab; 2009; 55(4):309-16. PubMed ID: 19828941
[TBL] [Abstract][Full Text] [Related]
6. Oxidative stress in elderly chronic renal failure patients: effects of renal replacement therapies on cell membrane fluidity.
Goi G; Massaccesi L; Baquero Herrera CJ; Musetti C; Ciurlino D; Cusi D; Bertoli S
J Nephrol; 2009; 22(5):630-6. PubMed ID: 19809996
[TBL] [Abstract][Full Text] [Related]
7. Investigation of protein oxidation and lipid peroxidation in patients with rheumatoid arthritis.
Baskol G; Demir H; Baskol M; Kilic E; Ates F; Karakukcu C; Ustdal M
Cell Biochem Funct; 2006; 24(4):307-11. PubMed ID: 16142689
[TBL] [Abstract][Full Text] [Related]
8. Oxidative stress in haemodialysis.
Loughrey CM; Young IS; Lightbody JH; McMaster D; McNamee PT; Trimble ER
QJM; 1994 Nov; 87(11):679-83. PubMed ID: 7820542
[TBL] [Abstract][Full Text] [Related]
9. Erythrocyte susceptibility to oxidative stress in chronic renal failure patients under different substitutive treatments.
Lucchi L; Bergamini S; Iannone A; Perrone S; Stipo L; Olmeda F; Caruso F; Tomasi A; Albertazzi A
Artif Organs; 2005 Jan; 29(1):67-72. PubMed ID: 15644086
[TBL] [Abstract][Full Text] [Related]
10. Plasma protein thiol oxidation and carbonyl formation in chronic renal failure.
Himmelfarb J; McMonagle E; McMenamin E
Kidney Int; 2000 Dec; 58(6):2571-8. PubMed ID: 11115093
[TBL] [Abstract][Full Text] [Related]
11. 8-hydroxy-2'-deoxyguanosine of leukocyte DNA as a marker of oxidative stress in chronic hemodialysis patients.
Tarng DC; Huang TP; Wei YH; Liu TY; Chen HW; Wen Chen T; Yang WC
Am J Kidney Dis; 2000 Nov; 36(5):934-44. PubMed ID: 11054349
[TBL] [Abstract][Full Text] [Related]
12. Oxidative stress in chronic renal failure patients treated by peritoneal dialysis.
Al-Hashimi AF; Mohammed FH; Al-Khazragi AS
Saudi Med J; 2004 Sep; 25(9):1186-92. PubMed ID: 15448763
[TBL] [Abstract][Full Text] [Related]
13. Changes in serum markers of oxidative stress with varying periods of haemodialysis.
Köken T; Serteser M; Kahraman A; Gökçe C; Demir S
Nephrology (Carlton); 2004 Apr; 9(2):77-82. PubMed ID: 15056266
[TBL] [Abstract][Full Text] [Related]
14. Biocompatible dialysis membranes and oxidative stress in patients wih end-stage renal disease on maintenance haemodialysis.
Abdel-Naeem NM; Kandell NF; El-Shamaa AA; Harba TM; Abdel-Hady AA
J Egypt Soc Parasitol; 2005 Dec; 35(3 Suppl):1173-97. PubMed ID: 16363293
[TBL] [Abstract][Full Text] [Related]
15. Impairment of glutathione biosynthetic pathway in uraemia and dialysis.
Alhamdani MS
Nephrol Dial Transplant; 2005 Jan; 20(1):124-8. PubMed ID: 15632350
[TBL] [Abstract][Full Text] [Related]
16. Investigation of albumin properties in patients with chronic renal failure.
Pieniazek A; Brzeszczynska J; Kruszynska I; Gwozdzinski K
Free Radic Res; 2009 Oct; 43(10):1008-18. PubMed ID: 19707919
[TBL] [Abstract][Full Text] [Related]
17. [Oxidative stress in end stage renal disease: evidence and association with cardiovascular events in Tunisian patients].
Fellah H; Feki M; Souissi M; Ghorbel H; Ben Abdallah T; Massy Z; Hedhili A; Ben Maiz H; Lacour B; Kaabachi N; Mebazaa A
Tunis Med; 2006 Nov; 84(11):724-9. PubMed ID: 17294900
[TBL] [Abstract][Full Text] [Related]
18. Comparison between hydroperoxides and malondialdehyde as markers of acute oxidative injury during hemodialysis.
Lucchi L; Iannone A; Bergamini S; Stipo L; Perrone S; Uggeri S; Gatti V; Ferrari F; Tomasi A; Albertazzi A
Artif Organs; 2005 Oct; 29(10):832-7. PubMed ID: 16185346
[TBL] [Abstract][Full Text] [Related]
19. Free and total plasma malondialdehyde in chronic renal insufficiency and in dialysis patients.
De Vecchi AF; Bamonti F; Novembrino C; Ippolito S; Guerra L; Lonati S; Salini S; Aman CS; Scurati-Manzoni E; Cighetti G
Nephrol Dial Transplant; 2009 Aug; 24(8):2524-9. PubMed ID: 19264746
[TBL] [Abstract][Full Text] [Related]
20. Iron supplementation and oxidative stress in patients with uremia.
Shetty JK; Prakash M
Indian J Physiol Pharmacol; 2007; 51(2):179-82. PubMed ID: 18175664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
